PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
34715090-6	2021	Therefore, we tested the leukotriene receptors CysLT1R/GPR17-selective antagonist Montelukast (MTK) for its efficacy to modulate the reactive state of microglia in order to ameliorate RGCs loss in experimental glaucoma.	montelukast	82-93	G protein-coupled receptor 17	Rattus norvegicus	55-60	
27881050-5	2016	Montelukast targets leukotriene receptors GPR17 and CysLTR1 and appears to invert leukotriene signaling, converting an inflammatory signal into an anti-inflammatory signal.	montelukast	0-11	G protein-coupled receptor 17	Rattus norvegicus	42-47	
34715090-19	2021	In the ON, OHT induction increased the number of GPR17+ cells, showing a significant reduction following MTK treatment.	montelukast	105-108	G protein-coupled receptor 17	Rattus norvegicus	49-54